Frame FM - Search Results

1

An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells.

Peitzsch C, Cojoc M, Hein L, Kurth I, Mäbert K, Trautmann F, Klink B, Schröck E, Wirth MP, Krause M, Stakhovsky EA, Telegeev GD, Novotny V, Toma M, Muders M, Baretton GB, Frame FM, Maitland NJ, Baumann M, Dubrovska A. Peitzsch C, et al. Among authors: frame fm. Cancer Res. 2016 May 1;76(9):2637-51. doi: 10.1158/0008-5472.CAN-15-2116. Epub 2016 Mar 16. Cancer Res. 2016. PMID: 26984757 Free article.

2

An internal polyadenylation signal substantially increases expression levels of lentivirus-delivered transgenes but has the potential to reduce viral titer in a promoter-dependent manner.

Hager S, Frame FM, Collins AT, Burns JE, Maitland NJ. Hager S, et al. Among authors: frame fm. Hum Gene Ther. 2008 Aug;19(8):840-50. doi: 10.1089/hum.2007.165. Hum Gene Ther. 2008. PMID: 18627247

3

Prostate cancer stem cells.

Lang SH, Frame FM, Collins AT. Lang SH, et al. Among authors: frame fm. J Pathol. 2009 Jan;217(2):299-306. doi: 10.1002/path.2478. J Pathol. 2009. PMID: 19040209 Free PMC article. Review.

4

Development and limitations of lentivirus vectors as tools for tracking differentiation in prostate epithelial cells.

Frame FM, Hager S, Pellacani D, Stower MJ, Walker HF, Burns JE, Collins AT, Maitland NJ. Frame FM, et al. Exp Cell Res. 2010 Nov 15;316(19):3161-71. doi: 10.1016/j.yexcr.2010.08.004. Epub 2010 Aug 19. Exp Cell Res. 2010. PMID: 20727882

5

Prostate cancer stem cells: do they have a basal or luminal phenotype?

Maitland NJ, Frame FM, Polson ES, Lewis JL, Collins AT. Maitland NJ, et al. Among authors: frame fm. Horm Cancer. 2011 Feb;2(1):47-61. doi: 10.1007/s12672-010-0058-y. Horm Cancer. 2011. PMID: 21761340 Free PMC article.

6

Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer.

Pellacani D, Packer RJ, Frame FM, Oldridge EE, Berry PA, Labarthe MC, Stower MJ, Simms MS, Collins AT, Maitland NJ. Pellacani D, et al. Among authors: frame fm. Mol Cancer. 2011 Jul 29;10:94. doi: 10.1186/1476-4598-10-94. Mol Cancer. 2011. PMID: 21801380 Free PMC article.

7

Cancer stem cells, models of study and implications of therapy resistance mechanisms.

Frame FM, Maitland NJ. Frame FM, et al. Adv Exp Med Biol. 2011;720:105-18. doi: 10.1007/978-1-4614-0254-1_9. Adv Exp Med Biol. 2011. PMID: 21901622 Review.

8

Differential cytotoxic activity of a novel palladium-based compound on prostate cell lines, primary prostate epithelial cells and prostate stem cells.

Ulukaya E, Frame FM, Cevatemre B, Pellacani D, Walker H, Mann VM, Simms MS, Stower MJ, Yilmaz VT, Maitland NJ. Ulukaya E, et al. Among authors: frame fm. PLoS One. 2013 May 10;8(5):e64278. doi: 10.1371/journal.pone.0064278. Print 2013. PLoS One. 2013. PMID: 23675532 Free PMC article.

9

HDAC inhibitor confers radiosensitivity to prostate stem-like cells.

Frame FM, Pellacani D, Collins AT, Simms MS, Mann VM, Jones GD, Meuth M, Bristow RG, Maitland NJ. Frame FM, et al. Br J Cancer. 2013 Dec 10;109(12):3023-33. doi: 10.1038/bjc.2013.691. Epub 2013 Nov 12. Br J Cancer. 2013. PMID: 24220693 Free PMC article.

10

DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferation.

Pellacani D, Kestoras D, Droop AP, Frame FM, Berry PA, Lawrence MG, Stower MJ, Simms MS, Mann VM, Collins AT, Risbridger GP, Maitland NJ. Pellacani D, et al. Among authors: frame fm. Cell Death Differ. 2014 May;21(5):761-73. doi: 10.1038/cdd.2013.202. Epub 2014 Jan 24. Cell Death Differ. 2014. PMID: 24464224 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page